HOME//NEWS/Efficient Advancement of iCamuno Biotherapeutics: Completing Three Rounds of Financing in Its First YearEfficient Advancement of iCamuno Biotherapeutics: Completing Three Rounds of Financing in Its First Year2022-03-31 10:10BACK2022.01.06Interpretation of Fate Therapeutics’ Latest ASH Data and Discussion on Future Development Trend of the iPSC Field - an Exclusive Interview with Dr. Liu Xiaodong2022.08.18iCamuno Biotherapeutics: Utilizing Three Platforms to Improve iPSC Differentiation EfficiencyBACK
